Syntis Bio
Phase 1Our oral therapies harness the small intestine’s unique biology to address global healthcare challenges ranging from rare genetic disorders to the most prevalent conditions.
Founded
2021
Focus
Drug Delivery
About
Our oral therapies harness the small intestine’s unique biology to address global healthcare challenges ranging from rare genetic disorders to the most prevalent conditions.
Funding History
1Total raised: $4.2M
Seed$4.2MUndisclosedMay 15, 2022
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile